# Efficacy and Safety of Spectacle Lenses With H.A.L.T. MAX Technology on High Myopia Control in Children and Adolescents

> **NCT07120737** · NA · NOT_YET_RECRUITING · sponsor: **Shanghai Eye Disease Prevention and Treatment Center** · enrollment: 224 (estimated)

## Conditions studied

- Myopia
- High Myopia

## Interventions

- **DEVICE:** H.A.L.T. MAX spectacles

## Key facts

- **NCT ID:** NCT07120737
- **Lead sponsor:** Shanghai Eye Disease Prevention and Treatment Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2028-03-01
- **Final completion:** 2028-12-01
- **Target enrollment:** 224 (ESTIMATED)
- **Last updated:** 2025-08-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07120737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07120737, "Efficacy and Safety of Spectacle Lenses With H.A.L.T. MAX Technology on High Myopia Control in Children and Adolescents". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07120737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*